.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
AstraZeneca
McKinsey
Cipla
Johnson and Johnson
Harvard Business School
Merck
Baxter
Healthtrust
Express Scripts

Generated: December 17, 2017

DrugPatentWatch Database Preview

AMINOSYN 7% Drug Profile

« Back to Dashboard

When do Aminosyn 7% patents expire, and when can generic versions of Aminosyn 7% launch?

Aminosyn 7% is a drug marketed by Icu Medical Inc and is included in two NDAs.

The generic ingredient in AMINOSYN 7% is amino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride. There are three hundred and forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical IncAMINOSYN 7%amino acidsINJECTABLE;INJECTION017673-002Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
Icu Medical IncAMINOSYN 7% (PH6)amino acidsINJECTABLE;INJECTION017673-006Nov 18, 1985RXNoNo► Subscribe► Subscribe► Subscribe
Icu Medical IncAMINOSYN 7% W/ ELECTROLYTESamino acids; magnesium chloride; potassium phosphate, dibasic; sodium chlorideINJECTABLE;INJECTION017789-002Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
Queensland Health
Farmers Insurance
Colorcon
Daiichi Sankyo
Dow
Johnson and Johnson
Chinese Patent Office
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot